Grant: Operating Grant - PA: Aboriginal Ways of Knowing and Two-eyed Seeing (Bridge)
University of Ottawa
$100,000.00
Targeting connexin and pannexin communication in demyelinating diseases
EF 2014-15
Résumé
Brain cells depend upon a lipid-rich sheath called myelin for their activity and for their protection. In MS, myelin loss precipitates vision, movement, and cognitive deficits. Toxic (damaging) and trophic (protective) signals transmitted through channel proteins known as connexins and pannexins, in part, signal this damage. Here, we propose to test whether demyelination can be mitigated by targeting connexin and pannexin channels, proteins. We began with the principle that many existing gap junction, connexin-hemichannel, and pannexin modulators are derived from plants. We then applied the two-eyed seeing approach defined by Mi'kmaq Elder Albert Marshall to CIHR as, "two-eyed seeing recognizes the benefits of seeing from one eye with the strengths of Indigenous ways of knowing, and to see from the other eye with the strengths of Western ways of knowing, and finally to use both of these eyes together." This approach was enabled as part of a unique CIHR-funded collaboration between academic scientists and Traditional Practitioners. Through discussion with the Elders and Healers of the Cree Nation of Eeyou Istchee and Nunavik, Canada, we asked how Traditional Practitioners treat the neurological symptoms of MS (i.e., which plants or medicines from food they use to reduce injury associated with demyelination). Why? Canada has one of the highest rates of MS in the world and yet First Nations Peoples have a significantly lower MS prevalence than the general population. Respecting and recognizing the effective Traditional Knowledge of our collaborators, together we collected the most relevant plants and through bioassay identified active compounds in the extracts that modulate connexin and pannexin communication. Here, we will validate their connexin and pannexin specificities and test the preclinical efficacy of these novel molecules and novel therapeutic targets to improve outcome in a mouse model of MS.
Programme
Operating Grant - PA: Aboriginal Ways of Knowing and Two-eyed Seeing (Bridge)
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
328707
Name
Bennett Steffany A
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Neurosciences, Mental Health and Addiction
Theme2
Biomedical
Prcname2
Cell Biology & Mechanisms of Disease
Projecttitle
Targeting connexin and pannexin communication in demyelinating diseases
Programtype2
Operating Grants
Orgnameinp2
University of Ottawa
Cihramount2
$100,000
Cihrequipment2
$0
Programname2
Operating Grant - PA: Aboriginal Ways of Knowing and Two-eyed Seeing (Bridge)
Keyworddelim
Adult Neural Stem Cells; Adult Oligoendrocyte Precursors; Connexin; Demyelination; Intercellular Communication; Medicinal Chemistry; Multiple Sclerosis; Pharmacology; Phytochemistry; Super Resolution Microscopy
Abstract
Brain cells depend upon a lipid-rich sheath called myelin for their activity and for their protection. In MS, myelin loss precipitates vision, movement, and cognitive deficits. Toxic (damaging) and trophic (protective) signals transmitted through channel proteins known as connexins and pannexins, in part, signal this damage. Here, we propose to test whether demyelination can be mitigated by targeting connexin and pannexin channels, proteins. We began with the principle that many existing gap junction, connexin-hemichannel, and pannexin modulators are derived from plants. We then applied the two-eyed seeing approach defined by Mi'kmaq Elder Albert Marshall to CIHR as, "two-eyed seeing recognizes the benefits of seeing from one eye with the strengths of Indigenous ways of knowing, and to see from the other eye with the strengths of Western ways of knowing, and finally to use both of these eyes together." This approach was enabled as part of a unique CIHR-funded collaboration between academic scientists and Traditional Practitioners. Through discussion with the Elders and Healers of the Cree Nation of Eeyou Istchee and Nunavik, Canada, we asked how Traditional Practitioners treat the neurological symptoms of MS (i.e., which plants or medicines from food they use to reduce injury associated with demyelination). Why? Canada has one of the highest rates of MS in the world and yet First Nations Peoples have a significantly lower MS prevalence than the general population. Respecting and recognizing the effective Traditional Knowledge of our collaborators, together we collected the most relevant plants and through bioassay identified active compounds in the extracts that modulate connexin and pannexin communication. Here, we will validate their connexin and pannexin specificities and test the preclinical efficacy of these novel molecules and novel therapeutic targets to improve outcome in a mouse model of MS.
Competitiondate
201503
Approvedterm2
1 yr 0 mth
Pinamesdelim
Bennett, Steffany A
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $100,000~ $0~